-
November 16, 2022
Global Mo-99 and I-131 Production Impacted by delay of BR2 Reactor Restarting
Nuclear Medicine Europe has reported a shortage of molybdenum-99 (Mo-99)/technetium-99m (Tc-99m) through and beyond the third week of November.
Read More -
May 20, 2022
RADIOCHEMIST (UNDER CLASSIFICATION REVIEW)
Eastern Health, Newfoundland has a vacancy for a RADIOCHEMIST (UNDER CLASSIFICATION REVIEW) PET/CT Facility Diagnostic Imaging Program – Molecular Imaging (Nuclear Medicine) Permanent, Full-Time Apply online at https://employment.easternhealth.ca Upon successfully applying for a vacancy then you will receive a confirmation email. If you do not receive this email please contact Recruitment 777-7777 ext 5-2 immediately To […]
Read More -
January 26, 2022
Alert: HFR Outage Will Impact Isotope Supply
NMEU COMMUNICATION 24 JAN 2022 Z January 26, 2022 On January 24, the Emergency Response Team (ERT) of Nuclear Medicine Europe (NMEu) communicated that there will be a delay in the restart of the HFR Reactor that will impact the supply of Mo-99 and Lu-177 in coming weeks. The delay is due to discovery of […]
Read More -
January 28, 2021
CARS Newsletter Winter 2021
Find the latest news in our community on CARS Newsletter January 2021.
Read More -
April 16, 2020
Update on the Radioisotopes Supply
The Security of Supply Working Group (SoS WG) Emergency Response Team (ERT) held a teleconference on 15 April 2020 to discuss the impact of the COVID-19 pandemic on Mo-99 and other radioisotope production. All organizations again reported that production operations continue normally within adjustments that have been taken against COVID-19, although production is being oriented […]
Read More -
January 25, 2020
New IAEA database “cyclotrons used for radionuclide production”
During the symposium International Symposium Trends in Radiopharmaceuticals ISTR–2019 held in Vienna, October 28-November 01, 2019 the International Atomic Energy…
Read More
Join us as a member
Filled out our membership form and join CARS Membership today for more radiopharmaceutical and scientific knowledge.